United Therapeutics (UTHR)

IVIVA Medical, Inc. • Lung Bioengineering Inc. • Lung Biotechnology PBC, a Delaware public benefit corporation • Miromatrix Medical Inc. • Revivicor, Inc. • United Therapeutics Europe, Ltd., a company incorporated • United Therapeutics Ireland Limited, a company incorporated • Unither Biotech Inc. • Unither Bioelectronics, Inc. • Unither Pharma, LLC ...

IRS number

521984749

UTHR stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$425.40

Low target

$302.00

High target

$600.00

Latest filings (excl ownership)

View all

8-K

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

30 Oct 24

Registration of securities for employees

1 Aug 24

8-K

United Therapeutics Corporation Reports Second Quarter 2024 Financial Results

31 Jul 24

United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors

27 Jun 24

Conflict minerals disclosure

31 May 24

8-K

United Therapeutics Corporation Reports First Quarter 2024 Financial Results

1 May 24

Annual report to shareholders

29 Apr 24

Transcripts

View all

UTHR

Earnings call transcript

2024 Q3

30 Oct 24

UTHR

Earnings call transcript

2024 Q2

31 Jul 24

UTHR

Earnings call transcript

2024 Q1

1 May 24

UTHR

Earnings call transcript

2023 Q4

21 Feb 24

UTHR

Earnings call transcript

2023 Q3

1 Nov 23

UTHR

Earnings call transcript

2023 Q2

2 Aug 23

UTHR

Earnings call transcript

2023 Q2

2 Aug 23

UTHR

Earnings call transcript

2023 Q1

3 May 23

UTHR

Earnings call transcript

2022 Q4

22 Feb 23

UTHR

Earnings call transcript

2022 Q3

2 Nov 22

Latest ownership filings

View all

Notice of proposed sale of securities

Notice of proposed sale of securities

Financial summary

Financial statements Chart UTHR financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q3 2024

UTHR institutional ownership history Ownership history

96.3% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	608	561	+8.4%
Opened positions	106	107	-0.9%
Closed positions	59	63	-6.3%
Increased positions	196	196	–
Reduced positions	219	185	+18.4%

13F shares	Current	Prev Q	Change
Total value	14.39 tn	13.53 tn	+6.4%
Total shares	45.26 mm	47.99 mm	-5.7%
Total puts	294.60 k	409.50 k	-28.1%
Total calls	194.10 k	368.20 k	-47.3%
Total put/call ratio	1.5	1.1	+36.5%

Largest owners	Shares	Value	Change
BLK BlackRock	5.32 mm	$1.91 tn	NEW
Vanguard	4.41 mm	$1.58 tn	-0.2%
Wellington Management	3.17 mm	$1.14 tn	-3.5%
Avoro Capital Advisors	2.86 mm	$1.02 tn	0.0%
Integrated Core Strategies	2.24 mm	$175.63 mm	0.0%
STT State Street	2.24 mm	$802.07 bn	-2.4%
Renaissance Technologies	2.16 mm	$772.38 bn	-0.9%
Geode Capital Management	1.09 mm	$391.46 bn	+4.3%
FMR	1.08 mm	$386.17 bn	+41.1%
LSV Asset Management	969.47 k	$347.41 mm	+0.3%

Largest transactions	Shares	Bought/sold	Change
BLK BlackRock	0.00	-5.47 mm	EXIT
BLK BlackRock	5.32 mm	+5.32 mm	NEW
C Citigroup	147.98 k	-1.48 mm	-90.9%
Amundi	65.32 k	-407.67 k	-86.2%
MS Morgan Stanley	401.46 k	-405.53 k	-50.3%
FMR	1.08 mm	+314.00 k	+41.1%
Aqr Capital Management	967.73 k	+248.22 k	+34.5%
Arrowstreet Capital, Limited Partnership	641.60 k	+202.92 k	+46.3%
Nordea Investment Management Ab	78.84 k	-189.67 k	-70.6%
HBCYF HSBC	225.24 k	+162.38 k	+258.3%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

UTHR insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
19 Dec 24	Mahon Paul A	Common Stock	Sale back to company	Dispose D	No	Yes	360.16	7,700	2.77 mm	36,710
19 Dec 24	Mahon Paul A	Common Stock	Option exercise	Acquire M	No	Yes	163.3	7,700	1.26 mm	44,410
19 Dec 24	Mahon Paul A	Share Tracking Award Common Stock	Option exercise	Dispose M	No	Yes	163.3	7,700	1.26 mm	37,350
19 Dec 24	Louis W Sullivan	Common Stock	Gift	Dispose G	No	No	0	1,851	0.00	3,200
18 Dec 24	Louis W Sullivan	Common Stock	Sell	Dispose S	No	No	382.245	100	38.22 k	5,051
18 Dec 24	Louis W Sullivan	Common Stock	Sell	Dispose S	No	No	381.3738	800	305.10 k	5,151
18 Dec 24	Louis W Sullivan	Common Stock	Sell	Dispose S	No	No	379.6741	944	358.41 k	5,951
18 Dec 24	Louis W Sullivan	Common Stock	Sell	Dispose S	No	No	377.46	400	150.98 k	6,895
18 Dec 24	Louis W Sullivan	Common Stock	Sell	Dispose S	No	No	375.03	2,700	1.01 mm	7,295
18 Dec 24	Louis W Sullivan	Common Stock	Sell	Dispose S	No	No	374.1667	1,962	734.12 k	9,995